Muscular dystrophy refers to a group of over 30 progressive muscle weakening disorders that are often disabling. Most forms of muscular dystrophy have symptoms that begin in early childhood, but some have symptoms that do not appear until early to late adulthood. The most common form of muscular dystrophy is Duchenne muscular dystrophy, which affects approximately 1 in 3,500 males. Girls are less affected by the common types of muscular dystrophy, which are inherited in an X-linked manner. There is no cure for any type of muscular dystrophy, and treatment is supportive and often includes use of wheelchairs, walkers, and breathing aids. Many forms of muscular dystrophy have an average life expectancy of late teens to early twenties, but with the introduction of supportive care and more information available about the disorders, the life expectancy is increasing.
Muscular Dystrophy Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Muscular Dystrophy below!
For more information on how to use Laverne, please read the How to Guide.
We have 649 products for the study of Muscular Dystrophy that can be applied to Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Western Blot from our catalog of antibodies and ELISA kits.